NASDAQ:SGMO
Sangamo BioSciences Stock News
$0.561
+0.0380 (+7.26%)
At Close: May 10, 2024
Sangamo Therapeutics (SGMO) Catches Eye: Stock Jumps 6.5%
12:02pm, Tuesday, 15'th Dec 2020
Sangamo Therapeutics (SGMO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase
Genomic Medicine: Slowly Moving To All At Once
08:50pm, Monday, 16'th Nov 2020
Gene regulation targeted at RNA or DNA has enormous potential for previously intractable nervous system disorders. Allele-specific gene regulation is a more precise approach targeting only the mutant
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q3 2020 Results - Earnings Call Transcript
12:21am, Thursday, 05'th Nov 2020
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q3 2020 Results - Earnings Call Transcript
